Klar; Jurgen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Klar; Jurgen.The latest application filed is for "1,3-thiazol-2-yl substituted benzamides".

Company Profile

0.16.26

Klar; Jurgen - Wuppertal DE
Klar; Jurgen - Berlin DE
Klar; Jurgen - Wupperta DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof Grant 11,208,400 - Giese , et al. December 28, 2	2021-12-28
1,3-thiazol-2-yl substituted benzamides Grant 11,142,523 - Davenport , et al. October 12, 2	2021-10-12
1,3-thiazol-2-yl Substituted Benzamides App 20200131169 - DAVENPORT; Adam James ; et al.	2020-04-30
Substituted 6-(1h-pyrazol-1-yl)pyrimidin-4-amine Derivatives And Uses Thereof App 20200055842 - GIESE; Anja ; et al.	2020-02-20
1,3-thiazol-2-yl substituted benzamides Grant 10,472,354 - Davenport , et al. Nov	2019-11-12
1,3-thiazol-2-yl Substituted Benzamides App 20190185466 - DAVENPORT; Adam James ; et al.	2019-06-20
1,3-thiazol-2-yl substituted benzamides Grant 10,202,369 - Davenport , et al. Feb	2019-02-12
Substituted oxopyridine derivatives and use thereof cardiovascular disorders Grant 10,183,932 - Rohrig , et al. Ja	2019-01-22
1,3-thiazol-2-yl substituted benzamides Grant 10,183,937 - Davenport , et al. Ja	2019-01-22
1,3-thiazol-2-yl substituted benzamides Grant 10,174,016 - Davenport , et al. J	2019-01-08
Substituted oxopyridine derivatives Grant 10,077,265 - Rohrig , et al. September 18, 2	2018-09-18
Substituted pyridobenzodiazepinone-derivatives and use thereof Grant 10,047,096 - Schall , et al. August 14, 2	2018-08-14
Substituted Oxopyridine Derivatives And Use Thereof In The Treatment Of Cardiovascular Disorders App 20180086742 - ROHRIG; Susanne ; et al.	2018-03-29
Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders Grant 9,822,102 - Rohrig , et al. November 21, 2	2017-11-21
Substituted Oxopyridine Derivatives App 20170283412 - ROHRIG; Susanne ; et al.	2017-10-05
Substituted oxopyridine derivatives Grant 9,765,070 - Rohrig , et al. September 19, 2	2017-09-19
Substituted Pyridobenzodiazepinone-derivatives And Use Thereof App 20170253602 - SCHALL; Andreas ; et al.	2017-09-07
Substituted Oxopyridine Derivatives And Use Thereof In The Treatment Of Cardiovascular Disorders App 20160368903 - ROHRIG; Susanne ; et al.	2016-12-22
Substituted Bipiperidinyl Derivatives App 20160318866 - BECKER-PELSTER; Eva Maria ; et al.	2016-11-03
Substituted Oxopyridine Derivatives App 20160272637 - ROHRIG; Susanne ; et al.	2016-09-22
Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders Grant 9,434,690 - Rohrig , et al. September 6, 2	2016-09-06
Substituted Oxopyridine Derivatives and Use Thereof in the Treatment of Cardiovascular Disorders App 20160052884 - ROHRIG; Susanne ; et al.	2016-02-25
Pdgfrbeta-fc Fusion Proteins And Uses Thereof App 20160009776 - Linden; Lars ; et al.	2016-01-14
Topical Ophthalmological Pharmaceutical Composition Containing Regorafenib App 20150328145 - BOTTGER; Michael ; et al.	2015-11-19
Topical Ophthalmological Pharmaceutical Composition Containing Sunitinib App 20150174096 - Bottger; Michael ; et al.	2015-06-25
Topical Ophthalmological Pharmaceutical Composition containing Axitinib App 20150164790 - Bottger; Michael ; et al.	2015-06-18
Topical Ophthalmological Pharmaceutical Composition Containing Cediranib App 20150165028 - Bottger; Michael ; et al.	2015-06-18
Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension Grant 9,040,566 - Klar , et al. May 26, 2	2015-05-26
Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors Grant 9,040,691 - Klar , et al. May 26, 2	2015-05-26
Topical Ophthalmological Pharmaceutical Composition containing Pazopanib App 20150141448 - Bottger; Michael ; et al.	2015-05-21
Topical Ophthalmological Pharmaceutical Composition Containing Regoragenib App 20140296301 - Bottger; Michael ; et al.	2014-10-02
Hydroxymethylaryl-substituted Pyrrolotriazines As Alk1 Inhibitors App 20140256718 - Klar; Jurgen ; et al.	2014-09-11
Topical Ophthalmological Pharmaceutical Composition containing Sorafenib App 20140235678 - Bottger; Michael ; et al.	2014-08-21
Topical Ophthalmological Pharmaceutical Composition Containing Regorafenib App 20140179745 - BOTTGER; Michael ; et al.	2014-06-26
Adenosine A1 Agonists For The Treatment Of Glaucoma And Ocular Hypertension App 20130210797 - Klar; Jurgen ; et al.	2013-08-15
Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension App 20120058983 - Klar; Jurgen ; et al.	2012-03-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.